Journal of Medicinal Chemistry 2004-11-18

Highly potent 1-aminocyclohexane-1-carboxylic acid substituted V2 agonists of arginine vasopressin.

Wioleta Kowalczyk, Adam Prahl, Izabela Derdowska, Olga Dawidowska, Jirina Slaninová, Bernard Lammek

Index: J. Med. Chem. 47(24) , 6020-4, (2004)

Full Text: HTML

Abstract

The synthesis and some pharmacological properties of two sets of analogues, one consisting of six peptides with 1-aminocyclohexane-1-carboxylic acid (Acc) in position 2 and the other with the amino acid in position 3, have been described. All the peptides were tested for their pressor, antidiuretic, and uterotonic in vitro activities. The Acc(2) modification has been shown to selectively modulate the activities of the analogues. Four of the compounds were highly potent antidiuretic agonists with different pressor and uterotonic activities. On the other hand, the 3-substituted counterparts failed to exhibit any of the activities. One exception was provided by the [Mpa(1),Acc(3),Val(4),D-Arg(8)]VP analogue, which exhibited antidiuretic activity matching that of AVP, yet, unlike AVP, it was fairly selective.


Related Compounds

Related Articles:

Drug design, in vitro pharmacology, and structure-activity relationships of 3-acylamino-2-aminopropionic acid derivatives, a novel class of partial agonists at the glycine site on the N-methyl-D-aspartate (NMDA) receptor complex.

2009-08-27

[J. Med. Chem. 52 , 5093-107, (2009)]

Application of 1-aminocyclohexane carboxylic acid to protein nanostructure computer design.

2008-02-01

[J. Chem. Inf. Model. 48(2) , 333-43, (2008)]

Influence of 1-aminocyclohexane-1-carboxylic acid in position 2 or 3 of AVP and its analogues on their pharmacological properties.

2003-08-01

[J. Pept. Res. 62(2) , 70-7, (2003)]

Nitroxyl peptides as catalysts of enantioselective oxidations.

2002-01-04

[Chemistry 8(1) , 84-93, (2002)]

Inhibition of neutral amino acid transport across the human blood-brain barrier by phenylalanine.

1995-03-01

[J. Neurochem. 64(3) , 1252-7, (1995)]

More Articles...